mayo clinic glp 1 drops Does menopause change how GLP-1 meds work? 🤯 researchers just uncovered a surprising connection between hormone therapy and weight loss on medicines like tirzepatide and semaglutide. Want the full breakdown? Glucagon-Like Peptide-1 Agonist Use in

Preparing for your consultation : Before your appointment, document: Your weight history, including previous weight loss attempts and outcomes Current medications and medical conditions Perimenopausal symptoms and their impact on daily life Dietary habits and physical activity levels Family history of obesity, diabetes, or thyroid conditions Specific concerns about weight gain and health goals Questions to discuss with your GP : "Am I eligible for referral to specialist weight management services that might consider GLP-1 medications?" "What are the realistic expectations for weight loss with these treatments?" "How would this medication interact with any HRT or other treatments I'm taking?" "What monitoring would be required during treatment?" "What happens when I stop the medicationwill weight return?" "Are there local NHS weight management services that might help?" "Would addressing my perimenopausal symptoms with HRT potentially help with my overall health?" Setting realistic expectations is crucial

The lack of clinical evidence contributes to the need for such future studies

Radiation and medications can damage the thyroid, although symptoms may not appear until long after treatment ends

Some patients experience balance problems, unsteadiness when walking, or coordination difficulties